Few people celebrate a milestone birthday by discussing stool samples, bowel preparation, or the architectural details of their colon. Nevertheless, the American College of Physicians recommends that asymptomatic adults at average risk of colorectal cancer begin regular screening at age 50. That advice matters because colorectal cancer screening does more than find cancer earlyit may prevent cancer by identifying precancerous polyps before they have a chance to become dangerous.
There is one important wrinkle: several other major U.S. medical organizations recommend starting average-risk screening at age 45. The difference can make colorectal cancer guidelines feel like competing GPS apps giving slightly different directions. The practical response is not to ignore all of them. It is to understand which recommendation applies to you, discuss your personal risk with a clinician, and complete an appropriate screening test on schedule.
What Does the ACP Recommend?
The American College of Physicians, commonly called the ACP, issued updated colorectal cancer screening guidance in 2023. It applies specifically to adults who have no symptoms and are considered at average risk.
The ACP suggests that clinicians:
- Begin colorectal cancer screening at age 50 for asymptomatic, average-risk adults.
- Discuss the uncertain balance of benefits and harms before routinely screening average-risk adults ages 45 through 49.
- Stop routine screening after age 75 or when life expectancy is 10 years or less.
- Choose the screening method through shared decision-making based on effectiveness, possible harms, cost, convenience, availability, and patient preferences.
For average-risk adults who follow its guidance, the ACP identifies three main strategies: a fecal immunochemical test or high-sensitivity guaiac fecal occult blood test every two years, a colonoscopy every 10 years, or flexible sigmoidoscopy every 10 years combined with a fecal immunochemical test every two years.
The ACP does not recommend stool DNA testing, CT colonography, capsule endoscopy, urine testing, or blood testing as its preferred screening strategies. This is one area where its recommendations differ from those of some other organizations.
Why Does Colorectal Cancer Screening Matter?
Colorectal cancer begins in the colon or rectum. Many cases develop from abnormal growths called polyps. Most polyps are harmless, but certain types can gradually acquire cellular changes and become cancerous.
Screening can interrupt that process. A colonoscopy, for example, allows a physician to see and remove suspicious polyps during the same procedure. Stool-based tests can detect hidden blood or other warning signals that lead to a diagnostic colonoscopy. Screening is therefore both an early-detection tool and, in some cases, a prevention tool.
Colorectal cancer remains one of the most commonly diagnosed cancers in the United States. Federal estimates for 2026 project approximately 158,850 new cases and 55,230 deaths. Although overall incidence and death rates have declined over time, progress has not been evenly distributed. Rates have been rising among younger adults, which is one reason the starting age has become such a lively medical debate.
Why Does the ACP Start at 50 When Other Groups Start at 45?
The ACP concluded that the evidence of net benefit is much stronger for adults ages 50 through 75 than for those ages 45 through 49. Colorectal cancer incidence has increased among younger adults, but the absolute number of cases in the 45-to-49 age group remains lower than in older age groups.
Starting earlier may prevent additional cancers and deaths. It also exposes more people to testing, false-positive results, follow-up procedures, costs, and uncommon but serious colonoscopy complications. The ACP placed greater weight on uncertainty surrounding that benefit-to-harm balance in average-risk adults younger than 50.
How Other U.S. Guidelines Differ
The U.S. Preventive Services Task Force recommends screening all average-risk adults from age 45 through 75. It assigns especially strong support to screening adults ages 50 through 75 while recognizing a moderate net benefit for ages 45 through 49.
The Centers for Disease Control and Prevention, National Cancer Institute, American College of Gastroenterology, and American Cancer Society also direct most average-risk adults to begin at 45. The American Cancer Society reaffirmed that starting age in its 2026 update and expanded its discussion of stool-based and blood-based screening options.
This disagreement does not mean one side thinks screening is wonderful and the other thinks it belongs in the attic with expired coupons. The organizations assess much of the same evidence but weigh modeling studies, direct clinical evidence, harms, resources, and patient burden somewhat differently.
What Should Adults Ages 45 to 49 Do?
Do not assume that the ACP recommendation means everyone should automatically wait until 50. Adults ages 45 through 49 should discuss screening with a healthcare professional, particularly because most current U.S. guidelines recommend beginning at 45 and many insurance plans cover screening from that age.
The conversation should include family history, previous polyps, inflammatory bowel disease, inherited cancer syndromes, symptoms, overall health, insurance coverage, and personal preferences. A person who strongly prefers a simple home FIT kit may reach a different decision from someone who would rather have a colonoscopy and, if normal, potentially avoid another screening procedure for 10 years.
Who Is Considered Average Risk?
Average risk generally means that a person does not have symptoms and does not have a medical or family history that substantially raises the likelihood of colorectal cancer.
The ACP age-50 guidance is not intended for people with:
- A personal history of colorectal cancer or certain colorectal polyps.
- A parent, sibling, child, or other significant family history of colorectal cancer or advanced polyps.
- Long-standing ulcerative colitis or Crohn’s disease involving the colon.
- Lynch syndrome, familial adenomatous polyposis, or another hereditary cancer syndrome.
- Previous radiation treatment involving the abdomen or pelvis.
- Possible colorectal cancer symptoms.
People in these groups may need screening earlier, more frequently, or with a specific method such as colonoscopy. The correct schedule depends on the exact risk factor, including which relative was affected and how old that person was at diagnosis.
Screening Is Not the Same as Diagnostic Testing
Screening is designed for people who feel well and do not have warning signs. Once symptoms appear, the goal changes from routine prevention to identifying the cause. That usually requires diagnostic evaluation rather than waiting for the next screening birthday.
Contact a healthcare professional promptly for symptoms such as:
- Blood in or on the stool.
- A persistent change in bowel habits.
- Unexplained diarrhea or constipation.
- A feeling that the bowel does not empty completely.
- Ongoing abdominal pain, cramping, or discomfort.
- Unexplained weight loss.
- Persistent fatigue or iron-deficiency anemia.
These symptoms often have noncancerous explanations, including hemorrhoids, infections, medication effects, or digestive disorders. Still, guessing is not a diagnostic strategy. Symptoms deserve evaluation at any age.
Comparing Colorectal Cancer Screening Tests
Fecal Immunochemical Test
The fecal immunochemical test, or FIT, checks a small stool sample for hidden human blood. It can be completed privately at home, requires no sedation, and usually does not require changes to diet or medication.
The advantages are convenience and low immediate risk. The trade-off is repetition: the test must be completed regularly. A positive result is not a cancer diagnosis, but it must be followed by a timely colonoscopy. A FIT kit quietly aging on top of the refrigerator is not technically a completed screening program.
High-Sensitivity Guaiac Fecal Occult Blood Test
This test also looks for hidden blood in stool, but it uses a chemical reaction rather than antibodies. It may require samples from more than one bowel movement and can involve dietary or medication restrictions. As with FIT, an abnormal result requires colonoscopy.
Colonoscopy
During colonoscopy, a flexible camera is used to examine the entire colon and rectum. Polyps can often be removed immediately, and suspicious tissue can be sampled.
A normal, high-quality colonoscopy may not need to be repeated for 10 years in an average-risk person. The procedure does require bowel preparation, time away from work or routine activities, and usually sedation with transportation home. Bleeding, perforation, and reactions related to sedation are uncommon but genuine risks.
Flexible Sigmoidoscopy
Flexible sigmoidoscopy examines the rectum and lower portion of the colon. Preparation is typically less extensive than for colonoscopy, and sedation may not be necessary. Because it does not inspect the entire colon, the ACP combines it with regular FIT testing. Abnormal findings may lead to a full colonoscopy.
Other Options in Non-ACP Guidelines
Other U.S. organizations include stool DNA tests, CT colonography, and selected newer blood-based tests among their options. These methods may help people who would otherwise avoid screening, but they have different abilities to detect precancerous lesions. Any abnormal non-colonoscopy test generally requires a follow-up colonoscopy to complete the screening process.
How to Choose the Best Screening Test
The best test is not necessarily the fanciest one or the test your neighbor enthusiastically describes during dinner. It is an evidence-supported test that is appropriate for your risk and that you are willing and able to complete correctly.
Questions worth discussing include:
- Can I reliably complete a home test every one or two years?
- Would I prefer a less frequent colonoscopy despite the preparation and sedation?
- Do I have health conditions that increase procedural or anesthesia risk?
- Can I take time off and arrange transportation?
- Is the test covered by my insurance?
- What will happen if the first test is positive?
Adherence matters enormously. A theoretically excellent test provides no protection while sitting unfinished in a bathroom cabinet.
When Should Screening Stop?
The ACP recommends stopping routine screening after age 75 or when life expectancy is 10 years or less. This reflects the time it may take for screening benefits to appear and the increasing risk of procedural complications with age.
Other organizations generally recommend individualized decisions from ages 76 through 85, based on overall health, previous screening, life expectancy, and preferences. An active 78-year-old who has never been screened may have more to gain than a 78-year-old with serious medical conditions and several previous normal colonoscopies.
Chronological age is therefore only part of the picture. Screening should not continue forever merely because the calendar reminder keeps popping up.
Reducing Colorectal Cancer Risk Beyond Screening
Screening remains essential because healthy habits cannot guarantee prevention. However, several lifestyle factors are associated with colorectal cancer risk.
Helpful long-term habits include maintaining regular physical activity, working toward a healthy weight, avoiding tobacco, limiting alcohol, eating more fruits, vegetables, whole grains, and fiber-rich foods, and reducing processed meat consumption. These choices support overall health as well as digestive health, but they are not substitutes for an appropriate screening schedule.
Practical Screening Experiences: What People Commonly Encounter
The following are composite educational scenarios based on common screening experiences. They are not individual patient records or medical recommendations.
The Home-Test Experience
A typical person receiving a FIT kit may first experience a brief wave of disbelief: “You want me to mail what?” The kit is usually much less dramatic than imagined. Instructions explain how to collect a very small sample without allowing it to mix with toilet water. The sample is sealed and returned to a laboratory.
The greatest challenge is often not physical discomfort but procrastination. The kit gets placed on a counter, moved to a drawer when visitors arrive, and rediscovered weeks later beside batteries of uncertain freshness. Setting a calendar reminder and completing it promptly can prevent this slow migration.
A negative result usually means repeating the test at the interval recommended by the clinician. A positive result does not prove cancer. Blood may come from polyps, hemorrhoids, or another source, but colonoscopy is needed to determine the cause. Skipping that follow-up leaves the screening process unfinished.
The First-Colonoscopy Experience
People who choose colonoscopy often say the preparation created more anxiety than the procedure itself. The day before the exam generally involves a clear-liquid diet and a prescribed bowel-cleansing solution. Modern preparations vary, so patients should follow their own instructions rather than advice from a cousin whose colonoscopy occurred during the flip-phone era.
Planning helps. Patients commonly stock approved clear liquids, chill the preparation if permitted, remain near a bathroom, and use soft toilet tissue or protective ointment to reduce irritation. Medication instructions deserve careful attention, especially for people taking diabetes drugs, blood thinners, or iron supplements.
On procedure day, a nurse reviews medical information, an intravenous line is placed, and sedation is often provided. Many patients remember little or nothing about the examination. Recovery commonly includes temporary bloating or gas. Because sedation affects judgment and coordination, another adult usually must drive the patient home.
The Experience of Finding a Polyp
Hearing that a polyp was removed can be unsettling, but removal is exactly what screening is designed to accomplish. The pathology report determines the polyp’s type and whether the next colonoscopy should occur sooner than the standard 10-year interval.
Some people interpret a polyp as evidence that they “failed” a health test. It is more accurate to view it as a successful interception. Screening found a potential problem before it caused symptoms or became more difficult to treat.
The Family-History Conversation
Another common experience begins when a relative casually mentions having had colon cancer or “a bunch of advanced polyps.” Suddenly, the person who thought they were average risk may need a different plan.
Useful details include the relative’s exact diagnosis, age at diagnosis, number and type of affected relatives, and any genetic testing. Collecting this information can feel awkward, but a slightly uncomfortable family conversation is preferable to an inaccurately delayed screening schedule.
The Main Lesson From These Experiences
Most people do not describe colorectal cancer screening as the highlight of their year. They do, however, frequently describe relief once it is completed. Clear instructions, a realistic plan, and a test suited to the individual make the process more manageable. The awkwardness is temporary; the preventive value can last for years.
Conclusion
The ACP recommends beginning regular colorectal cancer screening at age 50 for asymptomatic adults at average risk and generally stopping after age 75 or when life expectancy is 10 years or less. Its advice is more conservative than guidelines from the USPSTF, CDC, American Cancer Society, National Cancer Institute, and American College of Gastroenterology, which generally start average-risk screening at 45.
The disagreement should encourage an informed conversation, not inaction. Adults ages 45 and older should review their risk, available tests, insurance coverage, and preferences with a healthcare professional. People with symptoms, significant family history, inflammatory bowel disease, hereditary syndromes, or previous polyps may require earlier or more intensive evaluation.
Colorectal cancer screening may not be glamorous, but glamour has always been overrated in preventive medicine. Completing the right test at the right time can identify cancer earlierand sometimes prevent it altogether.
